167 related articles for article (PubMed ID: 35736804)
21. Etanercept for psoriasis in the pediatric population: experience in nine patients.
Hawrot AC; Metry DW; Theos AJ; Levy ML
Pediatr Dermatol; 2006; 23(1):67-71. PubMed ID: 16445417
[TBL] [Abstract][Full Text] [Related]
22. Treatment Options for Pediatric Psoriasis.
Madiraca D; Šitum M; Prkačin I; Ožanić Bulić S
Acta Dermatovenerol Croat; 2016 Aug; 24(3):175-80. PubMed ID: 27663917
[TBL] [Abstract][Full Text] [Related]
23. Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation.
Duarte A; Mebrahtu T; Goncalves PS; Harden M; Murphy R; Palmer S; Woolacott N; Rodgers M; Rothery C
Health Technol Assess; 2017 Nov; 21(64):1-244. PubMed ID: 29105621
[TBL] [Abstract][Full Text] [Related]
24. Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation.
Zangrilli A; Bavetta M; Bianchi L
Expert Opin Drug Saf; 2020 Apr; 19(4):433-438. PubMed ID: 32250180
[No Abstract] [Full Text] [Related]
25. Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation.
Corbett M; Chehadah F; Biswas M; Moe-Byrne T; Palmer S; Soares M; Walton M; Harden M; Ho P; Woolacott N; Bojke L
Health Technol Assess; 2017 Oct; 21(56):1-326. PubMed ID: 28976302
[TBL] [Abstract][Full Text] [Related]
26. Topical and Oral Therapies for Childhood Atopic Dermatitis and Plaque Psoriasis.
Frantz T; Wright EG; Balogh EA; Cline A; Adler-Neal AL; Feldman SR
Children (Basel); 2019 Nov; 6(11):. PubMed ID: 31694234
[TBL] [Abstract][Full Text] [Related]
27. Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities.
Bronckers IM; Paller AS; van Geel MJ; van de Kerkhof PC; Seyger MM
Paediatr Drugs; 2015 Oct; 17(5):373-84. PubMed ID: 26072040
[TBL] [Abstract][Full Text] [Related]
28. Topical treatments for chronic plaque psoriasis.
Mason AR; Mason J; Cork M; Dooley G; Hancock H
Cochrane Database Syst Rev; 2013 Mar; (3):CD005028. PubMed ID: 23543539
[TBL] [Abstract][Full Text] [Related]
29. Targeted Therapy for Pediatric Psoriasis.
Nogueira M; Paller AS; Torres T
Paediatr Drugs; 2021 May; 23(3):203-212. PubMed ID: 33811318
[TBL] [Abstract][Full Text] [Related]
30. Management of childhood psoriasis.
Cordoro KM
Adv Dermatol; 2008; 24():125-69. PubMed ID: 19256308
[TBL] [Abstract][Full Text] [Related]
31. Psoriasis in children.
Pinson R; Sotoodian B; Fiorillo L
Psoriasis (Auckl); 2016; 6():121-129. PubMed ID: 29387599
[TBL] [Abstract][Full Text] [Related]
32. Systemic Treatments in Pediatric Psoriasis: A Retrospective Single-Center Study.
Sahin G; Aydin F; Pancar Yuksel E
Arch Iran Med; 2021 Dec; 24(12):903-909. PubMed ID: 35014238
[TBL] [Abstract][Full Text] [Related]
33. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.
Mease PJ; Armstrong AW
Drugs; 2014 Mar; 74(4):423-41. PubMed ID: 24566842
[TBL] [Abstract][Full Text] [Related]
34. Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.
Elyoussfi S; Thomas BJ; Ciurtin C
Rheumatol Int; 2016 May; 36(5):603-12. PubMed ID: 26892034
[TBL] [Abstract][Full Text] [Related]
35. Biologics for pediatric psoriasis: A systematic review and meta-analysis.
Sun HY; Phan K; Paller AS; Sebaratnam DF
Pediatr Dermatol; 2022 Jan; 39(1):42-48. PubMed ID: 34888919
[TBL] [Abstract][Full Text] [Related]
36. Biologic therapy in erythrodermic and pustular psoriasis.
Levin EC; Debbaneh M; Koo J; Liao W
J Drugs Dermatol; 2014 Mar; 13(3):342-54. PubMed ID: 24595581
[TBL] [Abstract][Full Text] [Related]
37. Challenges in the treatment of psoriasis with biologics: vaccination, history of malignancy, human immunodeficiency virus (HIV) infection, and pediatric psoriasis.
Plachouri KM; Georgiou S
Int J Dermatol; 2019 Sep; 58(9):1008-1013. PubMed ID: 30891751
[TBL] [Abstract][Full Text] [Related]
38. Switching biologics in children with psoriasis: Results from the BiPe cohort.
Phan C; Beauchet A; Reguiai Z; Severino-Freire M; Mazereeuw-Hautier J; Bursztejn AC; Barbarot S; Hadj-Rabia S; Girard C; Phan A; Lacour JP; Lasek A; Abasq C; Brenaut E; Perrussel M; Droitcourt C; Mallet S; Piram M; Fougerousse AC; Barthélémy H; Balguérie X; Mahé E;
Pediatr Dermatol; 2022 Jan; 39(1):35-41. PubMed ID: 34888920
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic Review.
van Winden MEC; van der Schoot LS; van de L'Isle Arias M; van Vugt LJ; van den Reek JMPA; van de Kerkhof PCM; de Jong EMGJ; Lubeek SFK
JAMA Dermatol; 2020 Nov; 156(11):1229-1239. PubMed ID: 32822455
[TBL] [Abstract][Full Text] [Related]
40. Pediatric psoriasis: Evolving perspectives.
Eichenfield LF; Paller AS; Tom WL; Sugarman J; Hebert AA; Friedlander SF; Siegfried E; Silverberg N; Cordoro KM
Pediatr Dermatol; 2018 Mar; 35(2):170-181. PubMed ID: 29314219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
